Improvement Seen in Survival With Adjuvant Pembrolizumab in Kidney Cancer
Disease-free survival benefit was consistent with that seen in previous analyses; improvement in overall survival also seen
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.